LONDON, GREATER LONDON, UNITED KINGDOM, March 14, 2025 /EINPresswire / -- How Is the Vimizim Elosulfase Alfa Market Poised for Significant Expansion? Recent trends indicate a notable compound ...

NICE says it can approve BioMarin's ultra-rare drug treatment Vimizim, but has proposed real-world data collection and a price cap to overcome doubts about the drug's value, reports Andrew McConaghie.

BioMarin has gained FDA approval for its drug Vimizim for patients with a rare enzyme disorder. The condition, Morquio A syndrome affects around 3,000 patients in the developed world.

Here’s how it works. Mattresses in a box have made it easier than ever for sleepers to find a bed just right for your sleep style. Boxed beds have been flattened and rolled but once they’re ...

Q: What is the overall Box Office Collection of Warning? A: No Data Found.. Q: What is the Day 1 Box Office Collection of Warning? A: Warning collected ₹0.75 cr. on Day 1 at the India box office.

Q: Is Jail Flop or Hit? A: The performance of Jail was Flop. Q: What is the overall Box Office Collection of Jail? A:Jail collected ₹10.1 cr. at the worldwide box office. In India, it collected ...

The company’s products include VIMIZIM, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; VOXZOGO, a once daily injection ...

The company's portfolio comprises eight marketed products, namely, Aldurazyme, Naglazyme, Kuvan, Vimizim, Brineura, Palynziq, Voxzogo and Roctavian. Apart from a discounted PEG and P/E ...